Lipids as Targets for Renal Cell Carcinoma Therapy.

Stepanovska Tanturovska, Bisera; Manaila, Roxana; Fabbro, Doriano; Huwiler, Andrea (2023). Lipids as Targets for Renal Cell Carcinoma Therapy. International journal of molecular sciences, 24(4) MDPI 10.3390/ijms24043272

Preview

Text ijms-24-03272.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview

Kidney cancer is among the top ten most common cancers to date. Within the kidney, renal cell carcinoma (RCC) is the most common solid lesion occurring. While various risk factors are suspected, including unhealthy lifestyle, age, and ethnicity, genetic mutations seem to be a key risk factor. In particular, mutations in the von Hippel-Lindau gene (Vhl) have attracted a lot of interest since this gene regulates the hypoxia inducible transcription factors HIF-1α and HIF-2α, which in turn drive the transcription of many genes that are important for renal cancer growth and progression, including genes involved in lipid metabolism and signaling. Recent data suggest that HIF-1/2 are themselves regulated by bioactive lipids which make the connection between lipids and renal cancer obvious. This review will summarize the effects and contributions of the different classes of bioactive lipids, including sphingolipids, glycosphingolipids, eicosanoids, free fatty acids, cannabinoids, and cholesterol to renal carcinoma progression. Novel pharmacological strategies interfering with lipid signaling to treat renal cancer will be highlighted.

Interest & Impact

Downloads

5 since deposited on 02 Mar 2023
5 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item